Dr. Helene Bertrand Inc., 220-1940 Lonsdale Ave.
North Vancouver, British Columbia, V7M 2K2, Canada
NCT Number: NCT01963910
Capsaicin is a TRPV1 (transient receptor potential vanilloid 1) agonist, causing pain upon application. The investigators wish to determine whether mannitol blocks the effect of capsaicin application. As both cream bases are identical and mannitol addition is the only difference between the creams, if the mannitol cream is more effective in blocking the effect of capsaicin on the TRPV1 (transient receptor potential vanilloid 1) receptor, the investigators will have established that mannitol down-regulates or blocks the TRPV1 (transient receptor potential vanilloid 1) receptor.
Looking for future studies?
Notify Me19 year–80 year
All sexes
Interventional
Not applicable
North Vancouver, British Columbia, V7M 2K2, Canada
Capsaicin cream, which stimulates the TRPV1 (transient receptor potential vanilloid 1) receptor, causing a burning sensation, will be applied to both halves of the upper lip until a burning sensation with 8/10 intensity on an NRS (Visual Analog Scale) scale is experienced or five minutes have elapsed. Following this, the capsaicin cream will be wiped off and 30% mannitol in vehicle cream ( isopropyl palmitate, caprylic capric triglyceride, propylene glycol, ceteareth 20, cetearyl alcohol, glyceryl stearate, polyethylene glycol 100 stearate, dimethicone, octyldodecanol, lecithin, ethylhexyl glycerin and phenoxy ethanol) will be applied to one half of the upper lip, and vehicle cream alone will be applied to the other half. Cream assignment will be randomized and neither the subject nor the person applying the cream will know which half upper lip has which cream. Every minute for 10 minutes, the heat sensation felt in each half upper lip will be measured, using a visual scale from 0 to 10. A repeated measures analysis of variance will compare the NRS (Visual Analog Scale) scores from the 30% mannitol cream, to the NRS (Visual Analog Scale)scores from the vehicle cream. Significance will be accepted if P less than .05.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
applied to one half of the upper lip following removal of capsaicin cream.
Other names: mannitol cream, Mannitol, mannite, manna sugar, C6H8(OH)6
application to the other half of the upper lip following capsaicin cream removal
Time frame: 15 minutes per subject
Every minute after capsaicin cream application, subject will indicate NRS (numerical rating scale)heat score. When the score has reached 8/10 or after five minutes, the cream will be removed. The time needed to reach 8/10 heat score and the heat score achieved, or the score at five minutes will be recorded. Following application of the test creams, NRS (Visual Analog Scale) heat scores will be recorded once per minute for each side for 10 minutes.
Time frame: One hour
The subject will be observed for redness, swelling, or other side effects following the capsaicin cream application. These side effects will be recorded
Time frame: one hour
The subjects will be observed for side effects of the mannitol cream or the vehicle cream
University of British Columbia
Other
Acronym: LipTRP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03855111
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
New York, United States
View Trial DetailsNCT07271784
Biomarkers / Blood, Nervous System Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT04280562
Agnosia, Chronic Pain
New York, United States
View Trial DetailsNCT05837923
Nervous System Diseases, Neuralgia
Del Mar, California, United States
View Trial Details